|
WDR76 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.105400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.464200E-01 |
| Normal-vs-Stage2 |
8.712600E-01 |
| Normal-vs-Stage3 |
3.318300E-02 |
| Normal-vs-Stage4 |
5.558200E-01 |
| Stage1-vs-Stage2 |
5.325800E-01 |
| Stage1-vs-Stage3 |
2.315500E-03 |
| Stage1-vs-Stage4 |
3.107800E-01 |
| Stage2-vs-Stage3 |
1.404440E-01 |
| Stage2-vs-Stage4 |
6.737200E-01 |
| Stage3-vs-Stage4 |
4.424600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.627000E-01 |
| Normal-vs-AfricanAmerican |
6.583400E-01 |
| Normal-vs-Asian |
6.525200E-01 |
| Caucasian-vs-AfricanAmerican |
5.896000E-01 |
| Caucasian-vs-Asian |
6.203000E-01 |
| AfricanAmerican-vs-Asian |
7.395400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.018820E-01 |
| Normal-vs-Female |
3.421500E-03 |
| Male-vs-Female |
1.046380E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.476400E-01 |
| Normal-vs-Extreme_Weight |
1.574330E-02 |
| Normal-vs-Obese |
1.691030E-01 |
| Normal-vs-Extreme_Obese |
1.064010E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.752200E-02 |
| Normal_Weight-vs-Obese |
2.610800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.339790E-01 |
| Extreme_Weight-vs-Obese |
5.824100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.906200E-01 |
| Obese-vs-Extreme_Obese |
6.499900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.146770E-01 |
| Normal-vs-Age(41-60Yrs) |
4.749600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.991400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.234400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.533800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.253700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.371600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.447180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.673540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.382990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.157200E-03 |
| Normal-VS-Type2 PRCC |
3.864800E-01 |
| Normal-VS-KIRP CIMP |
2.780300E-02 |
| Normal-VS-Unclassified PRCC |
1.983240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.838800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.556200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.880400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.781800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.871400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.051700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.916400E-01 |
| Normal-vs-N1 |
3.048200E-02 |
| Normal-vs-N2 |
3.235200E-01 |
| N0-vs-N1 |
2.834300E-02 |
| N0-vs-N2 |
5.715200E-01 |
| N1-vs-N2 |
5.037800E-01 |
|
|
